Der Patient nahm vier Tage lang Ivermectin ein, musste dann ins Spital.
REUTERS 
A box of the drug Ivermectine, made by Biogaran, is pictured on the counter of a pharmacy, as the spread of the coronavirus disease (COVID-19) continues, in Paris, France, April 28, 2020. REUTERS/Benoit Tessier
Zur Startseite
Jetzt E-Paper lesen